Programmed cell death‐1 (PD‐1) and programmed death‐ligand 1 (PD‐L1) expression in PD‐1 inhibitor‐associated colitis and its mimics-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Programmed cell death‐1 (PD‐1) and programmed death‐ligand 1 (PD‐L1) expression in PD‐1 inhibitor‐associated colitis and its mimics

Published:2020-07-02 Issue:2 Volume:77 Page:240-249
ISSN:0309-0167
Container-title:Histopathology
language:en
Short-container-title:Histopathology

Author:

Cassol Clarissa A¹^ORCID,Owen Dwight²,Kendra Kari²,Braga Juarez R³,Frankel Wendy L¹,Arnold Christina A⁴

Affiliation:

1. Department of Pathology Division of Medical Oncology Ohio State University Columbus OH USA

2. Department of Internal Medicine Division of Medical Oncology Ohio State University Columbus OH USA

3. Institute of Health Policy, Management, and Evaluation University of Toronto Toronto Ontario Canada

4. The University of Colorado Anschutz Medical Campus Aurora CO USA

Publisher

Wiley

Subject

General Medicine,Histology,Pathology and Forensic Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/his.14115

Reference37 articles.

1. Cutaneous, gastrointestinal, hepatic, endocrine, and renal side-effects of anti-PD-1 therapy

2. Histopathological and immunophenotypic features of ipilimumab-associated colitis compared to ulcerative colitis

3. Immune checkpoint inhibitor colitis: the flip side of the wonder drugs

4. Immune modulator-induced changes in the gastrointestinal tract

5. PD-1 inhibitor gastroenterocolitis: case series and appraisal of ‘immunomodulatory gastroenterocolitis’

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel endoscopic scoring system for immune mediated colitis: a multicenter retrospective study of 674 patients;Gastrointestinal Endoscopy;2024-08

2. Enterocolitis y otras manifestaciones de toxicidad gastrointestinal asociada a inmunoterapia y terapia blanco: una revisión para el gastroenterólogo;Revista de Gastroenterología de México;2024-01

3. Enterocolitis and other immunotherapy and targeted therapy-related gastrointestinal manifestations: A review for gastroenterologist;Revista de Gastroenterología de México (English Edition);2024-01

4. PD-1-positive cells contribute to the diagnosis of inflammatory bowel disease and can aid in predicting response to vedolizumab;Scientific Reports;2023-12-04

5. PD-1-positive cells contribute to the diagnosis of inflammatory bowel disease and can aid in predicting response to vedolizumab;2023-08-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3